{
    "nctId": "NCT02621099",
    "briefTitle": "Hybrid Gamma Camera in Breast Surgery",
    "officialTitle": "First Use of a Hybrid Gamma Camera for Sentinel Lymph Node Localisation in Patients Undergoing Surgery for Primary Breast Cancer",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Agreement of detection rate between the camera and standard gamma probe in the SLNB",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Age \\> 18 years\n* Scheduled for a Sentinel Lymph Node Biopsy procedure for breast cancer\n* Has capacity to provide written 'informed consent'\n\nExclusion Criteria:\n\nNon-English speaking patients who have had:\n\n* a nuclear medicine procedure with administration of a radiopharmaceutical within 72 hours prior to the procedure;\n* prior systemic therapy for the breast cancer being scheduled for sentinel node biopsy (e.g. neoadjuvant chemotherapy and primary endocrine therapy).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}